Inchul Chung is a managing director at Andersen Consulting in Korea. With over twenty years of experience in management consulting, Inchul is involved in building the healthcare practice in Korea, focusing on the pharmaceutical, drug development, medical equipment, and digital healthcare sectors.
Prior to joining Andersen Consulting, Inchul was a partner at A.T. Kearney, Monitor Group, and IBM BCS. He successfully delivered numerous consulting projects encompassing mid- to long-term corporate strategy, new business strategy, growth strategy, R&D management strategy, overseas market entry strategy, group management strategy and subsidiary management systems, procurement innovation, and strategic sourcing.
Inchul also served as a CEO for a Korea’s KOSDAQ listed biopharmaceutical company focused on drug discovery and development. He was responsible for business development, strategic planning, M&A, investor and public relations, as well as corporate finance.
Throughout his consulting and industry experiences, Inchul has built intensive networks and relationships with management level of major Chaebol Companies in Korea, especially in the biopharmaceutical sector.
Firm

Location
Education
- Seoul National University, Ph.D.
- Seoul National University, MBA / BS
Languages
- Korean
- English
Areas of Specialization
- Corporate Strategy, Strategic Planning
- New Business Strategy
- M&A Advisory, Post-Merger Integration
- Strategic Management (Biotechnology & Healthcare)